A Visual Assay to Monitor T6SS-mediated Bacterial Competition

por Hachani, Abderrahman, Lossi, Nadine S., Filloux, Alain
Publicado 2013

Structure–function analysis of HsiF, a gp25-like component of the type VI secretion system, in Pseudomonas aeruginosa

por Lossi, Nadine S., Dajani, Rana, Freemont, Paul, Filloux, Alain
Publicado 2011

The Salmonella SPI-2 effector SseJ exhibits eukaryotic activator-dependent phospholipase A and glycerophospholipid : cholesterol acyltransferase activity

por Lossi, Nadine S., Rolhion, Nathalie, Magee, Anthony I., Boyle, Cliona, Holden, David W.
Publicado 2008

Coevolution of the ATPase ClpV, the Sheath Proteins TssB and TssC, and the Accessory Protein TagJ/HsiE1 Distinguishes Type VI Secretion Classes

por Förster, Andreas, Planamente, Sara, Manoli, Eleni, Lossi, Nadine S., Freemont, Paul S., Filloux, Alain
Publicado 2014

The HsiB1C1 (TssB-TssC) Complex of the Pseudomonas aeruginosa Type VI Secretion System Forms a Bacteriophage Tail Sheathlike Structure

por Lossi, Nadine S., Manoli, Eleni, Förster, Andreas, Dajani, Rana, Pape, Tillmann, Freemont, Paul, Filloux, Alain
Publicado 2013

Type VI Secretion System in Pseudomonas aeruginosa: SECRETION AND MULTIMERIZATION OF VgrG PROTEINS

por Hachani, Abderrahman, Lossi, Nadine S., Hamilton, Alexander, Jones, Cerith, Bleves, Sophie, Albesa-Jové, David, Filloux, Alain
Publicado 2011

A year in the life of German patients with COPD: the DACCORD observational study

por Buhl, Roland, Criée, Carl-Peter, Kardos, Peter, Vogelmeier, Claus, Lossi, Nadine, Mailänder, Claudia, Worth, Heinrich
Publicado 2016

“Real-life” inhaled corticosteroid withdrawal in COPD: a subgroup analysis of DACCORD

por Vogelmeier, Claus, Worth, Heinrich, Buhl, Roland, Criée, Carl-Peter, Lossi, Nadine S, Mailänder, Claudia, Kardos, Peter
Publicado 2017

Dual bronchodilation vs triple therapy in the “real-life” COPD DACCORD study

por Buhl, Roland, Criée, Carl-Peter, Kardos, Peter, Vogelmeier, Claus F, Kostikas, Konstantinos, Lossi, Nadine S, Worth, Heinrich
Publicado 2018

Treatment response in COPD: does FEV(1) say it all? A post hoc analysis of the CRYSTAL study

por Kostikas, Konstantinos, Greulich, Timm, Mackay, Alexander J., Lossi, Nadine S., Aalamian-Mattheis, Maryam, Nunez, Xavier, Pagano, Veronica A., Patalano, Francesco, Clemens, Andreas, Vogelmeier, Claus F.
Publicado 2019

Indacaterol/glycopyrronium reduces the risk of clinically important deterioration after direct switch from baseline therapies in patients with moderate COPD: a post hoc analysis of...

por Greulich, Timm, Kostikas, Konstantinos, Gaga, Mina, Aalamian-Mattheis, Maryam, Lossi, Nadine S, Patalano, Francesco, Nunez, Xavier, Pagano, Veronica A, Fogel, Robert, Vogelmeier, Claus F, Clemens, Andreas
Publicado 2018